September 15, 2008
The following new/updated information was posted to the NGC Web site the week of September 15, 2008.
Faculty of Sexual and Reproductive Healthcare
Progestogen-only implants.
Hartford Institute for Geriatric Nursing
Age-related changes in health. In: Evidence-based geriatric nursing protocols for best practice.
Comprehensive assessment and management of the critically ill. In: Evidence-based geriatric nursing protocols for best practice.
Dementia. In: Evidence-based geriatric nursing protocols for best practice.
Family caregiving. In: Evidence-based geriatric nursing protocols for best practice.
Health care decision making. In: Evidence-based geriatric nursing protocols for best practice.
Issues regarding sexuality. In: Evidence-based geriatric nursing protocols for best practice.
Managing oral hydration. In: Evidence-based geriatric nursing protocols for best practice.
Nutrition. In: Evidence-based geriatric nursing protocols for best practice.
Reducing adverse drug events. In: Evidence-based geriatric nursing protocols for best practice.
Substance misuse and alcohol use disorders. In: Evidence-based geriatric nursing protocols for best practice.
Infectious Diseases Society of America
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. This updates a previously published guideline summary.
National Institute for Health and Clinical Excellence (NICE)
Adalimumab, etanercept and infliximab for ankylosing spondylitis.
Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia.
Withdrawn Guideline Summaries
The guideline(s) listed below have been withdrawn from the NGC Web site because they no longer meet the NGC
Inclusion Criteria with respect to date, or because the guideline developer has indicated that they are no longer current. See the
Guideline Archive for a complete list of all guidelines that have been withdrawn from the NGC Web site.
Please refer to NGC’s
FAQ page if you have additional questions about guidelines recently withdrawn.
National Institute for Health and Clinical Excellence (NICE)
Guidance on the use of glitazones for the treatment of type 2 diabetes.
Newly Submitted
- AAN has released a new assessment on the use of natalizumab (Tysabri) for the treatment of multiple sclerosis.
- ICSI has updated their guidelines on routine prenatal care.
- PEBC has updated the following guidelines:
- Preoperative or postoperative therapy for the management of patients with stage II or III rectal cancer
- Preoperative or postoperative therapy for resectable esophageal cancer
To view a list of other guidelines in the NGC work queue, please visit our
Guidelines In Progress page.
Health Awareness Topics - September 2008
AHRQ News
A new Web-based
Glossary, developed by the Agency for Healthcare Research and Quality, offers an important reference tool for researchers, consumers, clinicians, insurers and others seeking information about the burgeoning science of comparative effectiveness. The new glossary was developed through the John M. Eisenberg Clinical Decisions and Communications Science Center, which is part of the AHRQ's Effective Health Care program.
Guideline Literature
Jaeschke R, Guyatt GH, Dellinger P, Schunemann H, Levy MM, Kunz R, Norris S, Bion J, GRADE Working Group.
Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008 Jul 31;337:a744.
BMJ 2008;337:a744.
See the related
Guideline Summary.
Conference News
- An AHRQ-sponsored Web conference on "Using Clinical Decision Support to Make Informed Patient Care Decisions" will be held on September 19, 2008, from 3:30 pm-5:00 pm EDT. The first in a series of four teleconferences on clinical decision support, this teleconference will address how clinical decision support – a clinical system, application, or process that helps health professionals make good patient care decisions – can help professionals improve the care delivered to patients. Registration is free.
- The 5th annual Guidelines International Network (G-I-N) conference, will be held October 1-3, 2008. Register online now. The theme of the conference is "Implementation in Practice." Special focus will be given to guideline implementation, collaboration in guideline production, evidence in guidelines, and guidelines and power. For further information and details about registration, please visit the G-I-N Conference Web site.
Healthy People 2010
See NGC's
Frequently Requested Search page for a selection of pre-set searches of NGC for guidelines related to the
Healthy People 2010 focus areas, as well as other public health and patient safety topics.
Recent U.S. Food and Drug Administration (FDA) Advisories
- September 11, 2008: Rituxan (rituximab): Revisions to prescribing information regarding a case of progressive multifocal leukoencephalopathy (PML).
- September 4, 2008: Tumor necrosis factor-alpha blockers (TNF blockers), Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab): FDA notified healthcare professionals that pulmonary and disseminated histoplasmosis, coccidioidomycosis, blastomycosis and other opportunistic infections are not consistently recognized in patients taking tumor necrosis factor-a blockers, which has resulted in delays in appropriate treatment, sometimes resulting in death.
NGC's Sister Resources
Find Innovations and
QualityTools classified by disease or clinical category, patient population, stage of care, setting of care, and more in AHRQ's
Health Care Innovations Exchange Web site.
Look for Quality Measures in AHRQ's
National Quality Measures Clearinghouse (NQMC).
Other Resources
To locate a previous issue of "What's New This Week," go to the
What's New Archive.
Questions or suggestions about the "What's New" feature are welcome -- please send e-mail to:
info@guideline.gov.
Submit your guidelines for inclusion in the National Guideline Clearinghouse!
Subscriptions
To sign up for our weekly NGC Update Service or to manage your subscriptions, visit the
Subscription Management page.
